FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200022714> ?p ?o ?g. }

• W3200022714 endingPage "9481" @default.
• W3200022714 startingPage "9476" @default.
• W3200022714 abstract "Anaplastic lymphoma kinase (ALK) fusion is a well-defined biomarker for ALK tyrosine kinase inhibitors (TKIs) treatment in non-small cell lung cancer (NSCLC). Alectinib, a second-generation ALK-TKI, has been shown to have significantly longer progression-free survival (PFS) than first-generation ALK inhibitors in untreated ALK-rearranged NSCLC patients. However, its clinical efficacy on rare ALK fusions remains unclear. Herein, two advanced NSCLC patients received first-line alectinib treatment, given their positive ALK fusion status as determined by immunohistochemistry (IHC) testing results. Patients showed limited clinical response (PFS: 4 months) and primary resistance to alectinib respectively. Molecular profiling using next-generation sequencing (NGS) further revealed a striatin (STRN)-ALK fusion in the first patient accompanied by MET amplification, and a LIM domain only protein 7 (LMO7)-ALK fusion in another patient without any other known oncogenic alterations. Both patients demonstrated improved survival after they switched to second-line crizotinib (PFS: 11 months) and ensartinib (PFS: 18 months), respectively, up till the last follow-up assessment. In conclusion, the clinical efficacy of ALK-TKIs including alectinib for lung cancer with uncommon ALK gene fusions is still under evaluation. This study and literature review results showed mixed responses to alectinib in NSCLC patients who harboured rare ALK fusions. Comprehensive molecular profiling of tumour is thus strongly warranted for precise treatment strategies." @default.
• W3200022714 created "2021-09-27" @default.
• W3200022714 creator A5019390307 @default.
• W3200022714 creator A5029185006 @default.
• W3200022714 creator A5038086148 @default.
• W3200022714 creator A5053056882 @default.
• W3200022714 creator A5055812068 @default.
• W3200022714 creator A5064805356 @default.
• W3200022714 creator A5072435699 @default.
• W3200022714 date "2021-09-19" @default.
• W3200022714 modified "2023-09-30" @default.
• W3200022714 title "Mixed responses to first‐line alectinib in non‐small cell lung cancer patients with rare <i>ALK</i> gene fusions: A case series and literature review" @default.
• W3200022714 cites W2086718822 @default.
• W3200022714 cites W2092974902 @default.
• W3200022714 cites W2107211259 @default.
• W3200022714 cites W2202341402 @default.
• W3200022714 cites W2292375548 @default.
• W3200022714 cites W2614672103 @default.
• W3200022714 cites W2624310346 @default.
• W3200022714 cites W2686045896 @default.
• W3200022714 cites W2738181268 @default.
• W3200022714 cites W2768896152 @default.
• W3200022714 cites W2791185794 @default.
• W3200022714 cites W2803694526 @default.
• W3200022714 cites W2839057355 @default.
• W3200022714 cites W2901237359 @default.
• W3200022714 cites W2925139051 @default.
• W3200022714 cites W2951165708 @default.
• W3200022714 cites W3007665819 @default.
• W3200022714 cites W3110493334 @default.
• W3200022714 cites W3200022714 @default.
• W3200022714 doi "https://doi.org/10.1111/jcmm.16897" @default.
• W3200022714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8500978" @default.
• W3200022714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34541785" @default.
• W3200022714 hasPublicationYear "2021" @default.
• W3200022714 type Work @default.
• W3200022714 sameAs 3200022714 @default.
• W3200022714 citedByCount "8" @default.
• W3200022714 countsByYear W32000227142021 @default.
• W3200022714 countsByYear W32000227142022 @default.
• W3200022714 countsByYear W32000227142023 @default.
• W3200022714 crossrefType "journal-article" @default.
• W3200022714 hasAuthorship W3200022714A5019390307 @default.
• W3200022714 hasAuthorship W3200022714A5029185006 @default.
• W3200022714 hasAuthorship W3200022714A5038086148 @default.
• W3200022714 hasAuthorship W3200022714A5053056882 @default.
• W3200022714 hasAuthorship W3200022714A5055812068 @default.
• W3200022714 hasAuthorship W3200022714A5064805356 @default.
• W3200022714 hasAuthorship W3200022714A5072435699 @default.
• W3200022714 hasBestOaLocation W32000227142 @default.
• W3200022714 hasConcept C104317684 @default.
• W3200022714 hasConcept C111829193 @default.
• W3200022714 hasConcept C117643217 @default.
• W3200022714 hasConcept C126322002 @default.
• W3200022714 hasConcept C143998085 @default.
• W3200022714 hasConcept C2776232967 @default.
• W3200022714 hasConcept C2776256026 @default.
• W3200022714 hasConcept C2778347629 @default.
• W3200022714 hasConcept C2779220645 @default.
• W3200022714 hasConcept C2779422266 @default.
• W3200022714 hasConcept C502942594 @default.
• W3200022714 hasConcept C54355233 @default.
• W3200022714 hasConcept C71924100 @default.
• W3200022714 hasConcept C86803240 @default.
• W3200022714 hasConceptScore W3200022714C104317684 @default.
• W3200022714 hasConceptScore W3200022714C111829193 @default.
• W3200022714 hasConceptScore W3200022714C117643217 @default.
• W3200022714 hasConceptScore W3200022714C126322002 @default.
• W3200022714 hasConceptScore W3200022714C143998085 @default.
• W3200022714 hasConceptScore W3200022714C2776232967 @default.
• W3200022714 hasConceptScore W3200022714C2776256026 @default.
• W3200022714 hasConceptScore W3200022714C2778347629 @default.
• W3200022714 hasConceptScore W3200022714C2779220645 @default.
• W3200022714 hasConceptScore W3200022714C2779422266 @default.
• W3200022714 hasConceptScore W3200022714C502942594 @default.
• W3200022714 hasConceptScore W3200022714C54355233 @default.
• W3200022714 hasConceptScore W3200022714C71924100 @default.
• W3200022714 hasConceptScore W3200022714C86803240 @default.
• W3200022714 hasFunder F4320322162 @default.
• W3200022714 hasIssue "19" @default.
• W3200022714 hasLocation W32000227141 @default.
• W3200022714 hasLocation W32000227142 @default.
• W3200022714 hasLocation W32000227143 @default.
• W3200022714 hasOpenAccess W3200022714 @default.
• W3200022714 hasPrimaryLocation W32000227141 @default.
• W3200022714 hasRelatedWork W2108851944 @default.
• W3200022714 hasRelatedWork W2235388618 @default.
• W3200022714 hasRelatedWork W2400744927 @default.
• W3200022714 hasRelatedWork W2516942920 @default.
• W3200022714 hasRelatedWork W2542474044 @default.
• W3200022714 hasRelatedWork W2624310346 @default.
• W3200022714 hasRelatedWork W2941535758 @default.
• W3200022714 hasRelatedWork W3132353474 @default.
• W3200022714 hasRelatedWork W3197633853 @default.
• W3200022714 hasRelatedWork W3199005851 @default.
• W3200022714 hasVolume "25" @default.
• W3200022714 isParatext "false" @default.
• W3200022714 isRetracted "false" @default.

• next